TCF7 and B-cell chronic lymphocytic leukemia: Moreover, Kienle et al. tested the ability of TCF7 gene to predict the genetic risk in CLL patients, defined by IgHV status, V3-21 usage, 11q-, and 17p-. TCF7 expression provided a high rate of correct assignment of patients at genetic risk [13].